ERGENYL Side Effects

6827231-5 | Aphasia, Asthenia, Dysphemia, Gait Disturbance, Miosis, Salivary Hypersecretion, Sedation, Speech Disorder, Vomiting
on Jul 01, 2010 Male patient from GERMANY , 30 years of age, was treated with Ergenyl (View Usage). Patient experienced the following unwanted or unexpected effects: aphasia (What is aphasia?), asthenia, dysphemia, gait disturbance, miosis, salivary hypersecretion, sedation, speech disorder, vomiting. Ergenyl dosage: . During the same period patient was treated with PROMETHAZINE (View Promethazine Review and Promethazine Label ). Patient was hospitalized.

6813504-9 | Aphasia, Asthenia, Dysphemia, Gait Disturbance, Miosis, Salivary Hypersecretion, Sedation, Speech Disorder, Vomiting
Patient was taking Ergenyl (View Usage). Patient had the following side effects: aphasia (What is aphasia?), asthenia, dysphemia, gait disturbance, miosis, salivary hypersecretion, sedation, speech disorder, vomiting on Jun 23, 2010 from GERMANY Additional patient health information: Male patient , 30 years of age, . Ergenyl dosage: . During the same period patient was treated with PROMETHAZINE (View Promethazine Review and Promethazine Label ). Patient was hospitalized.

6785025-3 | Anaemia, Gait Disturbance, Immunoglobulins Decreased, Infection Susceptibility Increased, Lymphadenopathy, Lymphopenia, Oedema, Paraneoplastic Syndrome, Performance Status Decreased
Adverse event was reported on Jun 15, 2010 by a Male patient taking Ergenyl (View Usage) (Dosage: ) was diagnosed with epilepsy (What is epilepsy?) and. Location: FRANCE , 44 years of age, After Ergenyl was administered, patient had the following side effects: anaemia, gait disturbance, immunoglobulins decreased, infection susceptibility increased, lymphadenopathy, lymphopenia, oedema, paraneoplastic syndrome, performance status decreased. During the same period patient was treated with LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), PANTOZOL (View Pantozol Review and Pantozol Label ), INDOMETHACIN (View Indomethacin Review and Indomethacin Label ), OXCARBAZEPINE (View Oxcarbazepine Review and Oxcarbazepine Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ). Patient was hospitalized and became disabled.

6749406-6 | Atrioventricular Block Complete, Bradycardia, Renal Failure
on May 18, 2010 Male patient from FRANCE , 70 years of age, was diagnosed with schizoaffective disorder, mania and was treated with Ergenyl (View Usage). Patient experienced the following unwanted or unexpected effects: atrioventricular block complete, bradycardia, renal failure. Ergenyl dosage: . During the same period patient was treated with QUILONUM (View Quilonum Review and Quilonum Label ), EUNERPAN (View Eunerpan Review and Eunerpan Label ). Patient was hospitalized.


6730603-0 | Atrioventricular Block Complete, Bradycardia, Renal Failure
on Nov 12, 2009 Male patient from GERMANY , 70 years of age, was diagnosed with schizoaffective disorder and was treated with Ergenyl (View Usage). Patient had the following side effects: atrioventricular block complete, bradycardia, renal failure. Ergenyl dosage: . During the same period patient was treated with FUROSEMID (View Furosemid Review and Furosemid Label ). Patient was hospitalized.

6729377-9 | Cell-mediated Immune Deficiency
Patient was taking Ergenyl (View Usage). After Ergenyl was administered, patient had the following side effects: cell-mediated immune deficiency on May 10, 2010 from FRANCE Additional patient health information: Female patient , 36 years of age, was diagnosed with grand mal convulsion and. Ergenyl dosage: 300mg Daily. During the same period patient was treated with TOPAMAX (View Topamax Review and Topamax Label ).

6696368-6 | Cell-mediated Immune Deficiency
Adverse event was reported on Apr 22, 2010 by a Female patient taking Ergenyl (View Usage) (Dosage: ) . Location: FRANCE , 36 years of age, Patient experienced the following unwanted or unexpected effects: cell-mediated immune deficiency.

6538193-2 | Atrioventricular Block Complete, Bradycardia, Renal Failure
on Jan 04, 2010 Male patient from FRANCE , 70 years of age, was diagnosed with prophylaxis and was treated with Ergenyl (View Usage). Patient had the following side effects: atrioventricular block complete, bradycardia, renal failure. Ergenyl dosage: . During the same period patient was treated with QUILONUM (View Quilonum Review and Quilonum Label ), EUNERPAN (View Eunerpan Review and Eunerpan Label ). Patient was hospitalized.

6428829-9 | Hypercholesterolaemia, Hypertriglyceridaemia, Pancreatitis Acute
on Oct 27, 2009 Male patient from FRANCE , 48 years of age, was treated with Ergenyl (View Usage). After Ergenyl was administered, patient had the following side effects: hypercholesterolaemia, hypertriglyceridaemia, pancreatitis acute. Ergenyl dosage: . During the same period patient was treated with ERGENYL CHRONO TABLETS (View Ergenyl Chrono Tablets Review and Ergenyl Chrono Tablets Label ).

6412550-7 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased, Hepatocellular Injury, Transaminases Increased
Patient was taking Ergenyl (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, hepatocellular injury, transaminases increased on Oct 15, 2009 from FRANCE Additional patient health information: Female patient , 63 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?) and. Ergenyl dosage: . During the same period patient was treated with VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ).

6395499-8 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased, Hepatocellular Injury, Transaminases Increased
Adverse event was reported on Sep 30, 2009 by a Female patient taking Ergenyl (View Usage) (Dosage: ) was diagnosed with bipolar disorder (What is bipolar disorder?) and. Location: FRANCE , 63 years of age, Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, hepatocellular injury, transaminases increased. During the same period patient was treated with VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ).

6388822-1 | Hypercholesterolaemia, Hypertriglyceridaemia, Pancreatitis Acute
on Sep 25, 2009 Male patient from FRANCE , 48 years of age, was treated with Ergenyl (View Usage). After Ergenyl was administered, patient had the following side effects: hypercholesterolaemia, hypertriglyceridaemia, pancreatitis acute. Ergenyl dosage: . During the same period patient was treated with ERGENYL CHRONO TABLETS (View Ergenyl Chrono Tablets Review and Ergenyl Chrono Tablets Label ).

6082603-4 | Blood Osmolarity Decreased, Hypokalaemia, Hyponatraemia
on Feb 09, 2009 Male patient from FRANCE , 51 years of age, was treated with Ergenyl (View Usage). Patient experienced the following unwanted or unexpected effects: blood osmolarity decreased, hypokalaemia, hyponatraemia. Ergenyl dosage: . During the same period patient was treated with FLUPENTIXOL (View Flupentixol Review and Flupentixol Label ), FLUPENTIXOL DECANOATE (View Flupentixol Decanoate Review and Flupentixol Decanoate Label ). Patient was hospitalized.

5655798-1 | Pseudodementia
Patient was taking Ergenyl (View Usage). Patient had the following side effects: pseudodementia on Feb 27, 2008 from FRANCE Additional patient health information: Female patient , 71 years of age, was diagnosed with epilepsy (What is epilepsy?) and. Ergenyl dosage: .

5558193-9 | Blood Electrolytes Decreased, Confusional State, Diarrhoea, Urine Barbiturates, Vomiting
Adverse event was reported on Dec 05, 2007 by a Female patient taking Ergenyl (View Usage) (Dosage: ) was diagnosed with epilepsy (What is epilepsy?) and. Location: FRANCE , 31 years of age, After Ergenyl was administered, patient had the following side effects: blood electrolytes decreased, confusional state, diarrhoea, urine barbiturates, vomiting. Patient was hospitalized.

5340935-9 | Apgar Score Low, Blood Ph Decreased, Convulsion Neonatal, Cyanosis, Dermatitis Diaper, Hyporeflexia, Hypotonia, Poor Sucking Reflex, Respiratory Failure
on May 23, 2007 Male patient from FRANCE , weighting 7.14 lb, was treated with Ergenyl (View Usage). Patient experienced the following unwanted or unexpected effects: apgar score low, blood ph decreased, convulsion neonatal, cyanosis, dermatitis diaper, hyporeflexia, hypotonia, poor sucking reflex, respiratory failure. Ergenyl dosage: . Patient was hospitalized.

5267606-1 | Apgar Score Low, Blood Ph Decreased, Convulsion Neonatal, Cyanosis, Dermatitis Diaper, Hyporeflexia, Hypotonia, Poor Sucking Reflex, Respiratory Failure
on Mar 08, 2007 Male patient from FRANCE , weighting 7.14 lb, was treated with Ergenyl (View Usage). Patient had the following side effects: apgar score low, blood ph decreased, convulsion neonatal, cyanosis, dermatitis diaper, hyporeflexia, hypotonia, poor sucking reflex, respiratory failure. Ergenyl dosage: . Patient was hospitalized.

5211530-7 | Respiratory Failure
Patient was taking Ergenyl (View Usage). After Ergenyl was administered, patient had the following side effects: respiratory failure on Jan 08, 2007 from FRANCE Additional patient health information: Male patient , weighting 7.14 lb, . Ergenyl dosage: . Patient was hospitalized.

5126039-9 | Autism
Adverse event was reported on Oct 03, 2006 by a Male patient taking Ergenyl (View Usage) (Dosage: ) . Location: FRANCE , child 3. years of age, Patient experienced the following unwanted or unexpected effects: autism (What is autism?).

5126038-7 | Autism Spectrum Disorder, Communication Disorder, Developmental Delay, Speech Disorder
on Oct 03, 2006 Female patient from FRANCE , child 5 years of age, was treated with Ergenyl (View Usage). Patient had the following side effects: autism spectrum disorder, communication disorder, developmental delay, speech disorder. Ergenyl dosage: .

5121131-7 | Breath Sounds Abnormal, Cold Sweat, Dyspnoea, Fatigue, Fluid Retention, Liver Function Test Abnormal, Oedema Peripheral, Urine Output Decreased, Weight Increased
on Sep 25, 2006 Female patient from FRANCE , 26 years of age, was diagnosed with hypomania, depression (What is depression?) and was treated with Ergenyl (View Usage). After Ergenyl was administered, patient had the following side effects: breath sounds abnormal, cold sweat, dyspnoea, fatigue, fluid retention, liver function test abnormal, oedema peripheral, urine output decreased, weight increased. Ergenyl dosage: . During the same period patient was treated with TRANYLCYPROMINE SULFATE (View Tranylcypromine Sulfate Review and Tranylcypromine Sulfate Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ). Patient was hospitalized.

4899269-9 | Alopecia, Gait Disturbance
Patient was taking Ergenyl (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia, gait disturbance on Jan 26, 2006 from FRANCE Additional patient health information: Female patient , 70 years of age, was diagnosed with tremor, depression (What is depression?), hypersensitivity, asthma (What is asthma?) and. Ergenyl dosage: . During the same period patient was treated with LITHIUM SULFATE (View Lithium Sulfate Review and Lithium Sulfate Label ), CROMOLYN SODIUM (View Cromolyn Sodium Review and Cromolyn Sodium Label ), EBASTINE (View Ebastine Review and Ebastine Label ), BECLOMETHASONE DIPROPIONATE (View Beclomethasone Dipropionate Review and Beclomethasone Dipropionate Label ), SALBUTAMOL SULFATE (View Salbutamol Sulfate Review and Salbutamol Sulfate Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), DILTIAZEM HYDROCHLORIDE (View Diltiazem Hydrochloride Review and Diltiazem Hydrochloride Label ).

4745769-1 | Condition Aggravated, Fanconi Syndrome Acquired, Gamma-glutamyltransferase Increased, Lipase Increased, Thrombocytopenia
Adverse event was reported on Aug 05, 2005 by a Female patient taking Ergenyl (View Usage) (Dosage: ) was diagnosed with epilepsy (What is epilepsy?) and. Location: FRANCE , child 7 years of age, Patient had the following side effects: condition aggravated, fanconi syndrome acquired, gamma-glutamyltransferase increased, lipase increased, thrombocytopenia. Patient was hospitalized.

4688560-7 | Jaundice Cholestatic, Pancreatic Pseudocyst, Pancreatitis Chronic
on May 23, 2005 Male patient from , 17 years of age, weighting 192.7 lb, was diagnosed with petit mal epilepsy and was treated with Ergenyl (View Usage). After Ergenyl was administered, patient had the following side effects: jaundice cholestatic, pancreatic pseudocyst, pancreatitis chronic. Ergenyl dosage: Not Reported. Patient was hospitalized.